Opaleye Management Inc. - JOUNCE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$917,823
-82.8%
669,944
-76.7%
0.22%
-86.2%
Q1 2023$5,328,0002,880,0001.60%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TRV GP II, LLC 572,829$1,340,000100.00%
TRV GP III, LLC 1,148,780$2,688,0001.17%
COWEN AND COMPANY, LLC 3,647,430$8,535,0000.82%
Octagon Capital Advisors LP 1,400,000$3,276,0000.56%
Deep Track Capital, LP 4,259,653$9,968,0000.46%
PFM Health Sciences, LP 4,094,488$9,581,0000.35%
RTW INVESTMENTS, LP 5,106,341$11,949,0000.28%
Omega Fund Management, LLC 275,513$645,0000.24%
Monarch Partners Asset Management LLC 228,370$534,0000.16%
Orbimed Advisors 2,928,900$6,854,0000.13%
View complete list of JOUNCE THERAPEUTICS INC shareholders